Life Planning Partners Inc Buys Shares of 64,843 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Life Planning Partners Inc bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, HoldingsChannel.com reports. The fund bought 64,843 shares of the exchange traded fund’s stock, valued at approximately $5,840,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after buying an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $141,284,000. Mirae Asset Securities USA Inc. increased its stake in shares of SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after purchasing an additional 300,000 shares during the last quarter. Assetmark Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after purchasing an additional 588,489 shares in the last quarter. Finally, Whittier Trust Co. lifted its stake in shares of SPDR S&P Biotech ETF by 3.3% in the 3rd quarter. Whittier Trust Co. now owns 311,027 shares of the exchange traded fund’s stock valued at $30,729,000 after purchasing an additional 9,976 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $90.77 on Friday. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The company’s fifty day moving average price is $91.92 and its two-hundred day moving average price is $96.21. The company has a market capitalization of $6.92 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.